Bunge Global SA (NYSE: BG) — The Baseline Rose, but So Did the Bar

Published: 2026-09-11 · Verdict: Hold · Entry price: $110 · Price target: $130 · Research confidence: High (84%)

Executive conclusion

Analyst Take

HOLD at $124.59; estimated fair value $130; preferred entry $110. Investment conviction: medium. Bunge is a materially larger and probably stronger agricultural merchant after acquiring Viterra, but the present quotation already requires a meaningful part of that improvement to survive normalization in crush margins. The best-supported conclusion is narrower than either pole of the debate. The prior report’s approximately $8 mid-cycle EPS estimate is no longer an adequate sole valuation anchor because it omitted Bunge’s already-published post-merger bridge, gave insufficient credit to the enlarged asset network, and preceded stronger synergy and physical biofuel-demand evidence. It has not, however, been disproved as a downside outcome by one favorable year. Management’s approximately $13 “current mid-cycle run-rate baseline” is also not a reported run rate: it starts with a then-current $7.75 guidance midpoint and adds assumed margin normalization, unfinished projects, cost and commercial synergies, debt reduction and repurchases. Those components have different probabilities and timetables. [S2][S3][S5]

My normalized EPS estimate is approximately $11.50, with a reasonable uncertainty band of roughly $10–$12.50. This is an analyst estimate, not company guidance. It triangulates the raised 2026 guidance midpoint of $9.50, the historical adjusted-earnings record, the increased $350 million cost-synergy objective, the separate $90 million network-and-commercial target, and the prospective project pipeline. It discounts the overlap between current favorable margins and management’s margin-normalization step, the probability that gross savings are partly absorbed by inflation or dis-synergies, and the fact that project, financing and share-count benefits are not yet fully visible in cash returns. At $124.59, BG trades at approximately 13.1 times the 2026 guidance midpoint, 10.8 times this estimate and 9.6 times management’s $13 construction. A 25% bear, 50% base and 25% bull probability framework supports approximately $127 before dividends and about $130 after one year of indicated distributions.

The central variant perception is therefore not “peak” versus “permanent plateau.” It is that the market is using an imprecise denominator. The stale bearish case treats standalone-style $8 earnings as the only relevant normal. The stale bullish case treats all of the $13 bridge as earned. Evidence instead supports a higher but still cyclical earnings base. Actual US soybean-oil use in biofuels was materially above 2025 in every reported month through June, and ADM raised its own guidance for the same renewable-fuel, crush and energy conditions. That corroborates the industry tailwind but also shows that much of Bunge’s uplift is external rather than unique execution. [S9][S11][S13]

The strongest counter-case is that renewable-fuel policy, enlarged global crush demand and the Viterra network have created a structural industry reset. If Bunge sustains adjusted EPS above $10 and adjusted ROIC above 10% through a weaker spread year, today’s price could prove conservative. The evidence against capitalizing that outcome now is concrete: management retained significant fourth-quarter uncertainty; grain merchandising guidance was reduced; first-half operating cash flow was negative $1.13 billion; debt rose to $15.21 billion; adjusted leverage increased from 1.6 to 1.9 times; and $2.85 billion, or roughly 21%, of June readily marketable inventory was valued with Level 3 inputs. EPA also decided 2025 exemptions before announcing that additional reallocation into 2026–27 would only be proposed, not automatically implemented. [S1][S3][S10][S21]

Evidence quality is high for filings, consideration, cash flow, debt, policy rules and reported physical demand; medium for adjusted earnings and realized cost savings; and low-to-medium for normalized spreads, network benefits and daily stock-move attribution. The near-term decision sequence is Q3 crush realization, disclosure of fourth-quarter bookings, net synergy conversion, Avondale and Morristown commercialization, seasonal working-capital release, final EPA reallocation treatment, and the pace of leverage reduction. The call would improve if normal-year EPS remains above $10, adjusted ROIC exceeds 10% while conventional ROIC and cash conversion improve, integration costs decline, and the new repurchase authorization is used only after debt normalizes. It would deteriorate if EPS trends below $8.50, claimed synergies fail to appear in segment cash contribution, Level 3 inventory or securitization dependence rises, project ramps slip, or policy and new capacity compress crush economics.

Changes since 2026-07-10

The stock closed at $114.32 on July 10 and $124.59 on September 10, an 8.98% increase. After the second-quarter release it traded as low as $102.81 intraday on July 30 and closed that day at $105.07; the subsequent recovery was 18.6% from the close and 21.2% from the intraday low. The earlier entry range never traded after publication. Price history is fact; attributing the recovery among earnings, policy, peer results and general risk appetite remains inference. [S18]

Bunge reported Q2 GAAP diluted EPS of $3.47 and adjusted EPS of $2.00, raised 2026 adjusted guidance to $9.25–$9.75, completed the remaining acquisition-related repurchase commitment, and increased its annual dividend to $2.88. Management raised its Viterra cost-synergy objective from $250 million to $350 million while retaining a separate $90 million network-and-commercial target. [S2][S3][S20]

Five inherited assumptions require correction. First, approximately $8 should no longer be used as the only post-merger mid-cycle reference, but one supportive half-year does not eliminate it as a downside case. Second, tangible common equity was previously understated because total disclosed intangibles were effectively double-counted: June shareholder equity of $15.953 billion less $3.354 billion of goodwill and $288 million of other intangibles equals approximately $12.31 billion, or $64.08 per June share and 1.94 times the current price. Third, the old $2.7 billion authorization is complete and a new $3 billion authorization was unused at June 30. Fourth, the previous Value-factor claim is stale because that exposure is absent from the supplied September snapshot. Fifth, EPA’s latest small-refinery announcement was dated August 31, not September 8. [S1][S10][S19]

The audit also found two underemphasized risks. Approximately $2.85 billion of Bunge’s $13.38 billion of readily marketable inventories was Level 3, reflecting unobservable freight and location adjustments, principally in interior Brazil and Canada. Separately, executives received a special one-time equity incentive based on cumulative run-rate cost synergies through 2028. Neither fact invalidates management’s claims, but together they increase the need to reconcile headline savings and adjusted leverage to net cash contribution and observable liquidity. [S1][S8]

Stock Price Action — Five-Year Event Map

The split-adjusted five-year record begins with a September 10, 2021 close of $76.14 and ends with a September 10, 2026 close of $124.59. The period’s intraday low was $67.40 on February 6, 2025; its high was $134.865 on June 3, 2026. The current price is 7.6% below that high and 84.9% above the five-year low. Over the latest 52 weeks the intraday range was $76.01–$134.865, placing the stock 63.9% above the low and again 7.6% below the high. It began 2026 at $89.08 and has appreciated 39.9% year to date. These prices come from the exchange-qualified NYSE:BG series; the explanations below are interpretations unless tied to a same-day disclosure. [S18]

1. September 2021 to May 2, 2022: $76.14 to $115.24, approximately +51%. The move coincided with tight agricultural balances, the Russia–Ukraine shock, high commodity prices and favorable crush economics. The price is fact. Allocating causality among war, crops, energy and company execution is inference.

2. May 2022 and September 2023 peaks to February 2025: roughly $115 to a $67.40 intraday low, approximately −41%. Bunge’s filing EPS reached $14.87 in 2023 before falling to $7.99 in 2024, while regulatory review prolonged the Viterra timetable. Earnings normalization and the timetable are facts; their respective contributions to the share decline cannot be isolated. [S22][S23]

3. February 6, 2025 to the July 2 Viterra close: $69.29 closing price to $81.39, approximately +17%; about +21% measured from the February intraday low. Completion removed transaction uncertainty and established the accounting share value used for Viterra consideration. It is reasonable, but not provable, to attribute part of the re-rating to the closing. [S1][S6]

4. July 2 to December 31, 2025: $81.39 to $89.08, approximately +9%. Integration updates, portfolio actions and repurchases supplied positive information, while weaker standalone margins and merger costs constrained reported earnings. The modest net rise was consistent with investors waiting for quantified post-merger economics.

5. December 31, 2025 to March 10, 2026: $89.08 to $119.75, approximately +34%. Management introduced the approximately $13 prospective baseline, $15-plus 2030 ambition, $3 billion authorization and minimum 50% discretionary-cash-return policy at Investor Day. The event plausibly supported the re-rating, although the stock had already advanced before March 10. [S4][S5]

6. March 10 to June 3: $119.75 to a $134.865 intraday high, approximately +13%. Bunge raised 2026 adjusted guidance from $7.50–$8.00 to $9.00–$9.50 on April 29. It closed at $126.31 that day and reached the June high as renewable-fuel and crush expectations strengthened. [S21]

7. June 3 to July 30: $131.41 close to $105.07, approximately −20%, with a $102.81 intraday low. The decline captured a sharp reduction in confidence despite a second guidance raise. Management’s acknowledged fourth-quarter uncertainty and weaker grain outlook offer a plausible explanation, but the tape alone cannot establish the cause. [S2][S3]

8. July 30 to September 10: $105.07 to $124.59, approximately +18.6%. The recovery coincided with ADM’s guidance increase, stronger EIA physical feedstock data and EPA’s August 31 exemption/reallocation announcement. Those events improved the external evidence set but do not prove that they caused the entire move. [S10][S11][S13]

The sequence rejects two simple narratives. The re-rating was not exclusively a Viterra event: the strongest 2026 industry evidence was shared with ADM and renewable-fuel markets. It was also not a generic defensive-staples move: the July drawdown showed considerable sensitivity to the visibility of crush and merchandising earnings. Conversely, the recovery demonstrates that investors did not treat one volatile quarter or negative initial reaction as thesis-breaking.

Verdict: Price action confirms that the market has raised its estimate of post-merger earnings power, not that management’s full bridge is proven. A price near the five-year high increases the amount of operating and cash-return evidence required for another durable re-rating; the July drawdown shows that confidence remains fragile.

Business Overview

Bunge connects crop producers with food, animal-feed and fuel customers. It originates grain and oilseeds from farms, cooperatives and elevators; stores and moves them by truck, rail, barge and vessel; merchandises commodities across locations and delivery periods; crushes oilseeds into protein meal and vegetable oil; refines oils for food and fuel feedstocks; mills grains; and supplies specialty fats, proteins and lecithin. Viterra broadened Bunge’s Canadian, Australian, Black Sea and other origination assets, complementing Bunge’s historically strong South American and oilseed-processing footprint. Management describes a system handling more than 200 million metric tons of commodities, with approximately 80 million tons of crush capacity, 13 million tons of refining capacity, more than 350 storage sites and over 50 port terminals in more than 50 countries. These are management representations of physical scale, not audited market-share statistics. [S5]

The business can be readily understood at the unit-economic level—buy, move, transform and resell crops—but consolidated quarterly earnings require a hedge-timing, basis-risk, working-capital and acquisition-accounting reconciliation.

For soybean processing, the gross economic unit is the value of the meal and oil produced from a bean less the delivered bean cost, processing expense, logistics and risk-management cost. Oil demand matters, but soybeans yield substantially more meal than oil by weight, so meal demand can determine whether an apparently strong oil market produces an attractive combined crush margin. Softseed economics are similar but vary by canola, rapeseed and sunflower supply. Grain merchandising earns origin basis, storage, quality-segregation, timing, destination and freight value. Refining earns the spread between crude oil and a customer-qualified refined product. Specialty ingredients add formulation, qualification and performance attributes to otherwise commodity-adjacent inputs.

Bunge ordinarily hedges flat-price commodity exposures. A hedge reduces outright commodity-price risk; it does not remove basis risk, crush-spread risk, location mismatch, volume, counterparty risk, liquidity requirements or accounting timing. A futures position can be marked through earnings before the physical inventory or customer contract it economically offsets. It may also require cash margin while the physical asset remains unsold. That is why GAAP results can reverse between quarters without an equivalent change in cumulative economics.

Segments and economic roles

Bunge now reports four segments. The filing renamed the third segment “Tropical Oils and Specialty Ingredients”; the draft’s longer “Other Oilseeds” name was stale. [S1]

The Q2 total of $1.226 billion should not be annualized. Adjusted total segment EBIT was $796 million, with mark-to-market timing the principal reason for the difference. Soybeans processed increased 24% to 11.524 million tons, softseeds processed rose 79% to 3.490 million tons, and grain volume increased sharply, but the comparison excludes Viterra from Q2 2025 because the acquisition closed after that quarter. Acquisition consolidation, not organic share gain, explains much of the apparent expansion. [S1][S2]

Soybean and softseed processing remain the core profit pool. FY2025 oilseed segment EBIT represented roughly three-quarters of total segment EBIT, but the quarterly mix can change materially. Grain merchandising can benefit from disruptions that hurt processing, while a good processing environment can offset weak grain basis or freight. The promise of Viterra is that a broader origin system increases the number of routes available to balance those conditions. That benefit must ultimately appear in throughput, utilization, profit per ton and lower downside volatility.

Customer value, contracts and recurrence

A feed producer needs reliable meal volume, protein specification and delivery timing. A food manufacturer needs safe, traceable and customer-qualified refined oil or fat. A renewable-fuel producer needs documented feedstock with the right carbon and regulatory attributes. Farmers value competitive bids, dependable settlement, storage and logistics. Bunge’s scale can reduce delivered cost and solve physical imbalances more efficiently than a local intermediary, but most products remain substitutable.

Revenue is operationally recurring because food, feed and fuel consumption repeat, but reported revenue and profit are unstable because commodity prices, acquisition mix and spreads—not subscriptions—determine the invoice and margin.

Revenue was $59.2 billion in 2021, $67.2 billion in 2022, $59.5 billion in 2023, $53.1 billion in 2024 and $70.3 billion in 2025; first-half 2026 revenue was $45.9 billion. The 2025 and 2026 increases primarily reflect Viterra consolidation and commodity prices rather than comparable organic value creation. A $1 increase in commodity selling price can raise revenue with little economic benefit if input cost increases by the same amount. Throughput, processing spread, adjusted segment EBIT, cash conversion and returns on capital are more informative than nominal revenue growth. [S1][S6][S18][S22]

The company’s contracts range from spot purchases and sales to forward physical commitments and customer supply arrangements. Recurrence comes from repeat need and network reliability, not contractual lock-in. Farmers can redirect crops where alternative elevators and transport exist; large customers routinely multi-source. The quality of recurrence is therefore much closer to a utility-like physical need with volatile economics than to recurring software revenue.

Recognized and unrecognized assets

The balance sheet recognizes plants, elevators, ports, inventories, receivables, leases, goodwill and identified intangibles. Internally built route knowledge, farmer relationships, customer qualification, risk systems, logistics coordination and regulatory operating permissions are not separately capitalized at full economic value.

The principal economically valuable assets not fully recognized on the balance sheet are the origin-to-destination network, operating relationships, route optionality and optimization capability; their value exists only if they improve utilization, delivered cost, resilience or returns.

At June 30, goodwill was $3.354 billion and other intangible assets were $288 million. Bunge finalized Viterra purchase accounting in Q2 and increased acquisition goodwill by $574 million, principally after revising property, plant, equipment and affiliate valuations. Goodwill is a residual justified largely by expected synergies and the assembled workforce; it is not independent evidence of a moat. Correct tangible common equity is approximately $12.31 billion, not the much lower figure implied by double-counting goodwill within total disclosed intangibles. [S1]

There is also replacement-value optionality in old ports, elevators and logistics corridors, but replacement cost does not equal economic value. An asset is worth more than book only when location, permits and demand support cash returns. Conversely, specialized processing assets can be worth less than book if policy changes, crop flows or competing capacity strand them.

Security and tax form

BG is a Swiss registered share trading directly on the NYSE; it is not an ADR, master limited partnership, partnership interest or K-1 security.

Each registered share generally carries voting rights, and dividends are approved within the Swiss corporate framework. Holder-specific Swiss withholding, treaty-reclaim and tax consequences vary by investor and should be assessed separately. The security’s Swiss incorporation does not convert it into a depositary receipt. [S7]

Verdict: Bunge is understandable as a physical spread and logistics business but complicated in consolidated reporting. Essential repeat demand and the enlarged network support throughput and survival. They do not create subscription economics, broad customer captivity or stable margins. The network is economically valuable only to the extent that it produces measurable utilization, cash flow and returns.

Industry Dynamics

The addressable market is the global origination, movement, processing and refining of grains and oilseeds. It is measured in hundreds of millions of tons and tens of billions of dollars, but nominal market size is a poor proxy for processor economics because commodity prices pass through revenue. Bunge sources from surplus regions including Brazil, Argentina, North America, Australia and the Black Sea and sells into domestic and deficit markets. Geography is not passive diversification: weather, export taxes, currencies, freight, sanctions, farmer selling and government controls constantly change the most profitable route.

The market is global, enormous and growing at low-single-digit underlying volume rates, while nominal market value fluctuates with commodity prices and conveys little about the processing profit pool.

USDA’s latest available oil-crops outlook before publication projected 2026/27 global soybean crush of 384.8 million metric tons, almost 11 million tons above revised 2025/26. It forecast global soybean meal and soybean-oil use growth of about 3%. For the United States it projected a record 4.52-billion-bushel soybean crop, 2.78 billion bushels of crush and 320 million bushels of ending stocks. These are forecasts, not harvested facts. They show why demand growth alone is not sufficient for the bull case: crop supply and effective processing capacity are expanding alongside end use. [S12]

Structure of competition

ADM is the closest listed operating peer. Cargill and Louis Dreyfus are private global merchants; COFCO is a state-linked global competitor; Wilmar has substantial Asian processing and tropical-oil exposure. Regional crushers, farmer cooperatives, port operators, exporters, millers and integrated energy companies compete asset by asset. Bunge’s acquisition of Viterra removed one independent global merchant, but it did not remove local competition for crops or customers.

Building a comparable global network is difficult. A new entrant would require storage, processing, port and transport access; farmer and customer relationships; commodity-risk systems; substantial working-capital credit; food-safety and environmental compliance; and operating knowledge across legal jurisdictions. Environmental permitting and community acceptance slow new ports and processors. Credit is a structural barrier because a commodity price increase can consume billions of dollars of working capital even when economic margins are unchanged.

Yet the barrier to replicating the entire network differs from the barrier to adding the marginal ton. An existing processor, cooperative or energy partner can expand a regional crush plant without recreating Bunge. When renewable-fuel demand raises expected returns, incumbents add capacity. That supply response can compress the very spread that justified investment.

Industry profitability is cyclical rather than structurally high: a small group of global merchants faces formidable platform-entry barriers, but incumbent and regional capacity additions compete away processing windfalls.

Bunge’s management-defined adjusted ROIC ranged from 23.7% in 2021 and 25.5% in 2022 to 8.1% in 2025. Conventional ROIC ranged from 14.7% to 6.9%. Such dispersion is inconsistent with stable monopoly rent. It is consistent with a network that monetizes scarcity and dislocation but cannot prevent capacity and crop responses. [S5]

The profit pool

Farmers, seed and input providers, transport operators, merchants, processors, refiners, fuel producers and end customers divide the chain’s economics. In a short crop, farmers can capture scarcity through higher crop prices while processors suffer low utilization. When oil and meal demand outrun available crush capacity, processors capture wider spreads. When logistics are disrupted, merchants with alternative routes can earn basis and freight value. Policy credits may accrue to fuel producers rather than feedstock processors unless demand tightens the underlying oil balance.

Bunge’s strongest position is when its assets provide several ways to originate, transform and deliver a constrained product. Its weakest is when too much capacity competes for crop or customer demand remains adequately supplied. This is why “more biofuel demand” and “higher Bunge margins” are related but not identical propositions.

Renewable-fuel policy and observed demand

The final US rule established biomass-based diesel requirements of 8.86 billion and 8.95 billion RINs for 2026 and 2027, with 0.21 billion and 0.25 billion RINs of specified small-refinery reallocation, producing total applicable volumes of 9.07 billion and 9.20 billion. The broader total-renewable-fuel volumes were 26.81 billion and 27.02 billion RINs after reallocation. EPA announced the rule on March 27; the Federal Register publication was April 1. [S9]

Physical demand subsequently strengthened. US soybean-oil inputs to biofuel production were 978 million pounds in January, 1.058 billion in February, 1.283 billion in March, 1.224 billion in April, 1.434 billion in May and 1.556 billion in June 2026. Every month exceeded the comparable 2025 level; June was approximately 49% higher than June 2025’s 1.043 billion pounds. This verifies the direction of physical demand. It does not establish the processor margin retained by Bunge. [S11]

EPA’s August 31 action is more nuanced than the draft suggested. It decided 34 petitions, granting 18 full exemptions, 11 partial exemptions, three denials and finding two ineligible; 1.76 billion RINs were exempted for 29 refineries. EPA said it would propose by the end of October to reallocate 100% of the difference between projected and actual 2025 exemptions into 2026 and 2027 obligations. The exemption decisions are agency action; the additional reallocation remains a prospective proposal. [S10]

Brazilian blending schedules, Argentine export taxes, European renewable rules, Indonesian mandates and US clean-fuel tax implementation also affect flows. Management’s own baseline assumes supportive US and Brazilian biofuel policy, normalized Argentine taxes and less disruptive Black Sea conditions. Those are explicit economic assumptions, not permanent features of the industry. [S5]

Competition direction

Competition is becoming more concentrated at the global-company level after Bunge absorbed Viterra, but more intense at the marginal processing-capacity level as attractive biofuel economics draw investment.

ADM provides an independent control. It raised 2026 adjusted EPS guidance to $5.15–$5.60 from $4.15–$4.70 and reported Q2 Ag Services & Oilseeds profit of $867 million, up 129%, citing margin expansion, North American crush, the finalized RVO, energy prices and execution. ADM also disclosed approximately $100 million of positive mark-to-market and timing effects in the segment. This confirms a broad industry uplift and simultaneously cautions against attributing Bunge’s entire improvement to merger execution. [S13]

The best competitive outcome for Bunge is not permanent wide spreads; it is relative resilience. If Bunge can maintain higher utilization, source around regional crop failures and use the Viterra network to outperform peers during normalization, the combination creates value even if industry margins fall. If its returns decline in line with or worse than ADM, the combination mainly added scale and fixed capital.

Foreign cost threat

Low-cost foreign labor is not the principal threat; low-cost crops, favorable currencies, export taxes, logistics advantages and new processing capacity in Brazil, Argentina, the Black Sea and Asia can redirect margins and impair higher-cost assets.

Processing is capital-, energy- and logistics-intensive. A weak local currency can improve export competitiveness; an Argentine tax change can alter farmer selling; a Black Sea disruption can create merchandising opportunities and physical losses simultaneously. Bunge’s multiple-origin footprint mitigates dependence on one region but also exposes the company to more jurisdictions, controls and currencies. [S1][S3][S6]

Verdict: This is a durable and essential but not predictably high-return industry. Observed biofuel demand has strengthened the volume case, while crop growth, capacity response and unfinished policy implementation preserve spread risk. Consolidation improves network resilience; it does not repeal price-taking or the supply-side capital cycle.

Competitive Position

Bunge’s defensible advantage is a global origin-processing-destination network supported by working-capital capacity, risk management and operating knowledge. Viterra broadened the origin footprint and added grain, storage and logistics assets that can feed Bunge’s processing system. The economic mechanism is cost and optionality: denser origination can improve procurement; more routes can reduce empty logistics legs; multiple origins can support customer reliability; and combined data and commercial teams can direct crop toward the highest-value use.

A valid moat test asks what would deteriorate if the advantage disappeared. Without origin density, Bunge would pay more for crop or operate plants below capacity. Without destination relationships and logistics, it would capture fewer basis and freight opportunities. Without risk systems and financing, it could not safely carry the inventory and receivables required to serve global customers. The measurable outcomes are therefore capacity utilization, delivered cost, segment EBIT per ton, liquidity during price spikes, downside volatility and ROIC relative to capital cost.

Synergy evidence and its limits

Management increased the Viterra cost-synergy objective from $250 million to $350 million after integration work identified more savings. It retained a separate $90 million network-and-commercial target. At Investor Day the original program had achieved a $119 million run rate by December 2025, with approximately $220 million expected during 2026. That is positive evidence: the savings have identifiable workstreams and an observed early run rate. [S3][S5]

The evidence is incomplete in three ways. First, public disclosure does not reconcile gross savings to net segment profit after inflation, stranded costs, retention expense and dis-synergies. Second, stronger industry margins can mask weak integration or make savings appear more valuable. Third, the board approved a special executive equity award that vests against cumulative run-rate cost-synergy targets through 2028, while the underlying targets and detailed definitions are not fully public. Incentive alignment can accelerate integration, but it also raises the importance of auditing the metric selected for reward. [S8]

The $90 million commercial target is harder to observe than procurement or head-count savings. It can arise from better routing, higher utilization or customer coordination, but those outcomes are also affected by crops and market spreads. Evidence should therefore include pro-forma utilization, incremental volume contribution and profit per ton, not only management’s total EBIT bridge.

Nature of competition

Competition is based on delivered price, reliable execution, product specification, origin access, logistics, financing and risk management rather than proprietary product scarcity.

Meal, grain and many oils are standardized. A global network can lower delivered cost and improve reliability, but Bunge ordinarily remains a price-taker for both crop inputs and commodity outputs. The company can earn temporary local advantages when freight, storage or processing is constrained; competitors and trade flows eventually respond.

Customer switching costs are generally low in commodity products and moderate only where qualification, traceability, formulation, dedicated logistics or supply assurance matter.

Specialty fats, proteins and lecithin can require customer testing and formulation, increasing friction. Traceability programs, food-safety history and integrated supply arrangements can also matter. These higher-friction products remain a minority of group economics, and customer qualification can itself slow the ramp of new facilities such as Morristown.

Brand relevance

Consumer brands matter little to consolidated economics; Bunge’s economically important reputation is institutional reliability, food safety, traceability and execution rather than consumer preference.

A food or fuel customer may value Bunge as a counterparty, but that reputation does not normally permit premium pricing independent of market spreads. The IFF soy-protein and lecithin acquisition and specialty projects can increase formulation value over time, yet the company remains predominantly a B2B processor and merchant. [S1][S5]

Peer comparison

ADM is the cleanest listed operating comparison, though not a perfect one. It shares oilseed crush, origination, merchandising and biofuel exposure but also owns substantial carbohydrate and nutrition operations. Cargill and Louis Dreyfus are economically closer global-network peers but lack continuously traded equity. Wilmar has a different geographic and tropical-oil mix. Tyson and Cal-Maine may share a “farm products” taxonomy but occupy different points in the chain and are not valid merchant/crush valuation peers.

At September 10, ADM’s $86.91 price equaled approximately 16.2 times the midpoint of its raised 2026 adjusted EPS range, versus 13.1 times for Bunge. The comparison suggests Bunge is not expensive relative to the most visible listed peer, but it does not prove mispricing. ADM’s earnings mix, accounting history, capital structure and policy sensitivity differ; both companies’ guidance improved in the same favorable environment. [S13][S18]

Return evidence and moat depth

Management’s adjusted ROIC series was 23.7% in 2021, 25.5% in 2022, 20.0% in 2023, 12.6% in 2024 and 8.1% in 2025. Conventional ROIC was 14.7%, 15.8%, 14.6%, 10.1% and 6.9%. Management’s prospective mid-cycle baseline targets approximately 12.5% adjusted and 9.5% conventional ROIC. The peak returns show that the network can monetize dislocation; the decline shows that those returns were not protected from normalization. [S5]

Bunge’s adjusted calculation recognizes that a dollar invested in liquid, hedged crop inventory does not require the same permanent capital as a dollar in a plant. That distinction is economically legitimate. It can still flatter returns if inventory needs cannot fall without reducing throughput or if location, basis and margin requirements prevent immediate cash conversion. Both conventional and adjusted returns should be monitored with cash flow.

A one-year post-merger record cannot prove lower cyclicality. Soybean and softseed strength offset some weak grain conditions in Q2, which is supportive. The stronger test is whether combined-company EBIT and ROIC decline less than peers when a major region experiences weak crush spreads, abundant capacity or a poor crop.

Verdict: Bunge has a genuine scale-and-network advantage, strengthened by Viterra, but its moat is shallow. The advantage can improve cost, utilization, liquidity and resilience; it does not produce broad captivity or independent pricing power. Higher synergy targets are confirming evidence, while volatile returns, external margin dependence and limited net-savings disclosure remain material disconfirming evidence.

Growth History and Forward Opportunities

Historical reported growth is not a conventional compounding record. Revenue rose with commodity prices in 2021–22, declined through 2024, and increased sharply in 2025 as Viterra entered the accounts for six months. Filing diluted EPS moved from $13.45 in 2021 to $10.52 in 2022, $14.87 in 2023, $7.99 in 2024 and $4.91 in 2025. The path is a cycle plus a transaction, not a stable organic trend. [S6][S18][S22][S23]

The outlook for Bunge’s products is constructive for oilseed throughput and biofuel feedstocks, but profit growth depends on crop supply, meal demand, effective processing capacity, policy and utilization as well as end-use volume.

Viterra integration

Cost synergies are the highest-quality growth opportunity because management has meaningful control over procurement, organization, shared services and operations. The $350 million objective is larger than the original $250 million. The $90 million network-and-commercial target seeks to route Viterra-originated crops through combined processing and destination assets more profitably. Cost savings should be judged by declining cash integration costs and incremental cash EBIT; network benefits require utilization and contribution evidence. [S3][S5]

The most important distinction is between a run-rate claim and an earned annual result. A run rate can reflect actions completed late in a period without a full-year income-statement benefit. It can also be measured before implementation costs. The appropriate scorecard is gross action, cash cost, net benefit, segment placement and capital employed.

In-flight projects

Management assigns approximately $1.30 per share to projects already in flight by 2030. The Q2 call described several milestones: the Destrehan Bunge–Chevron joint-venture crush facility was expected around the end of Q3; a barge-unloading expansion was expected during August; Morristown was producing soy protein concentrate but not at full scale and still required customer qualification; Avondale’s expanded multi-oil refining capacity was expected to start around August; and the Westzaan/Amsterdam refinery project remained targeted for the end of Q1 2027, with contribution ramping later. [S3][S5]

Commissioning is not commercial success. Morristown’s specialty product could earn better margins because formulation and qualification matter, but those same requirements delay utilization. Avondale is closer to commodity-adjacent refining and depends on feedstock, customers and regional spreads. Destrehan links Bunge more closely to renewable feedstock demand through its Chevron partnership. Westzaan promises structural operating efficiencies but requires construction completion and a controlled transition from existing assets.

Management states that growth projects are evaluated against an approximately 1.7-times-WACC hurdle, risk-adjusted by geography and business. That is a demanding stated hurdle. Realized returns should include startup losses, working capital, maintenance and capital overruns rather than EBITDA at nameplate capacity. [S5]

Biofuels, food and feed

Renewable diesel, biodiesel and sustainable aviation fuel can increase demand for soybean, canola and other oils. Bunge’s multi-oil footprint provides flexibility, but feedstocks compete. Used cooking oil, animal fats, imported oils, corn oil and policy-specific carbon scores influence which product captures the value. Strong soybean-oil demand is supportive only if it tightens the combined oil-and-meal crush balance faster than crop and capacity expand.

Food demand is less cyclical than fuel policy, but refined-oil customers can trade down, shorten purchase commitments or resist pricing. Management acknowledged challenging food-customer behavior and shorter buying during Q2. Animal-feed demand is vital because meal is the larger physical output of soybean crush. USDA’s forecast of growth in both meal and oil use is more supportive than an oil-only demand story. [S3][S12]

Specialty mix and portfolio actions

Bunge paid $105 million for IFF’s lecithin, soy-protein-concentrate and related crush assets in March 2026. The preliminary allocation included approximately $60 million of PP&E, $48 million of inventory and only $1 million of goodwill. That limits purchase-accounting opacity relative to Viterra, but commercial return remains unknown while customer qualification and plant ramp continue. [S1]

The company also continued portfolio pruning. A previously announced sale of European margarines and spreads carried approximately $202 million of assets and $62 million of liabilities held for sale at June 30 and had been agreed for approximately $239 million of cash, subject to closing adjustments. In September, Bunge agreed to sell two Viterra-inherited Brazilian sugarcane mills to COFCO International for undisclosed consideration. Simplification may improve strategic focus; undisclosed or incomplete proceeds prevent a final return judgment. [S1][S15]

The 2030 ambition

Management’s $15-plus adjusted EPS ambition consists of the approximately $13 bridge plus roughly $2 from growth and further capital allocation. It is a target, not contracted revenue. It assumes policy support, project returns, realized synergies, normalized financing and share repurchases at sensible prices. The longer the forecast horizon, the more important it is to model capital needed to achieve EPS rather than only the numerator.

Verdict: Growth quality is mixed. Cost synergies are tangible self-help; network benefits and specialty mix are plausible; in-flight projects are real but not fully commercial; and biofuel demand is observed but external. The $15-plus ambition should be valued only through staged probabilities and demonstrated cash returns.

Financial Quality

Multi-year income statement and earnings quality

The 2023 gross margin above 8% and $14.87 filing EPS capture the favorable crush cycle. By 2025, gross margin was below 5%, corporate and integration costs increased, and GAAP EPS fell to $4.91. H1 2026 improved, but Viterra makes the revenue and volume base discontinuous. [S1][S5][S6][S18][S22][S23]

A material data reconciliation is necessary. Company Financials calculated FY2025 diluted EPS at approximately $4.22 because its annual output appears to divide $816 million of attributable income by the year-end 193.4 million shares. The audited 10-K reports $4.91 using approximately 166 million weighted-average diluted shares because the 65.6 million Viterra shares were issued halfway through the year. The filing controls. This is precisely why transaction-year per-share data must be reconciled to the filing rather than accepted mechanically. [S6][S18]

GAAP versus adjusted

Q1 2026 GAAP EPS was $0.35 versus $1.83 adjusted, with adverse mark-to-market timing of $1.28 per share among the main adjustments. Q2 reversed: GAAP EPS was $3.47 versus $2.00 adjusted, with favorable mark-to-market timing contributing $1.67. First-half GAAP and adjusted EPS consequently converged at $3.81 and $3.83. [S1][S2][S21]

That convergence supports management’s claim that much derivative volatility is timing. It does not validate every adjustment. Acquisition and integration expenses are cash costs, even if investors reasonably exclude them from steady-state earnings. Restructuring can become economically recurring when a company repeatedly acquires, closes or reconfigures assets. Adjusted EPS also does not solve the working-capital cash requirement created by physical inventories and margin deposits.

Accounting is reasonable for a hedged physical merchant but not inherently conservative: GAAP contains genuine timing noise, while adjusted results exclude cash integration costs and rely on management’s classification of notables.

A disciplined earnings-quality process should show GAAP, adjusted EPS, cumulative mark-to-market timing, cash integration expense, restructuring, acquisition accounting and share-count changes together. First-half convergence is reassuring; the number and magnitude of merger-era adjustments still reduce comparability.

Cycle and return on capital

Earnings are above the merger-affected 2025 trough and below the 2023 super-cycle peak; current conditions may approximate a favorable mid-cycle, but the combined company has not been tested through a complete margin down-cycle.

Management’s 2026 adjusted guidance of $9.25–$9.75 is 25% above FY2025 adjusted EPS at the midpoint, but below 2021–23 adjusted results. ADM’s simultaneous increase shows that shared crush, energy and policy conditions explain part of the recovery. It is therefore inappropriate to label every dollar above 2025 as recurring Viterra value. [S2][S5][S13]

Business profitability is cyclical but not uniformly poor: trailing returns only modestly exceed management’s capital costs, peak returns were exceptional, and the prospective post-Viterra baseline targets approximately 12.5% adjusted and 9.5% conventional ROIC.

At Q2, trailing adjusted ROIC was 8.4% and conventional ROIC was 6.8%; excluding construction in progress and excess cash, management cited 9.3% and 7.2%. Cash return on equity was 10.8% against a stated 7.2% cost of equity. All are management-defined non-GAAP or analytical measures and should be paired with debt, securitization and cash conversion. [S3]

The historical adjusted ROIC average is elevated by extraordinary 2021–23 conditions. Conventional ROIC is lower because it does not give the same treatment to marketable inventory and other adjustments. Neither measure alone answers whether Viterra created value. The decisive test is whether incremental after-tax cash return on the full acquisition and integration investment exceeds the relevant capital cost through normal and weak spread environments.

Balance-sheet evolution

Viterra doubled much of the balance sheet. At June 30, Bunge held $593 million of cash, $3.931 billion of trade receivables, $15.461 billion of inventory and $11.945 billion of net PP&E. Debt consisted of $4.588 billion short term, $1.200 billion current long term and $9.426 billion long term. Shareholder equity was $15.953 billion and noncontrolling interests were $1.389 billion. [S1][S18]

The decline in gross debt from December to June can look inconsistent with the filing’s statement that debt increased. The table’s 2025 aggregate uses short- and long-term categories from Company Financials, while the filing’s directly comparable total debt was $14.051 billion at December 31 and $15.214 billion at June 30. For current leverage, the filing definition governs. The increase reflected short-term borrowing and March note issuance, partly offset by April maturities. [S1][S18]

RMI, leverage and liquidity

Management gives a 70% credit to readily marketable inventories and adds derecognized receivables funding when calculating adjusted net debt. At June, RMI was $13.376 billion and adjusted leverage was 1.9 times, versus 1.6 times at Q1. Net debt exceeded RMI by approximately $1 billion after RMI had exceeded net debt by about $400 million three months earlier. Management reported $9.7 billion of committed facilities, $8.8 billion unused and $2.4 billion available under its commercial-paper program. [S3][S21]

RMI deserves substantial but not unlimited credit. Crops with active markets and hedges are more liquid than fixed assets, and selling them ordinarily releases debt. Nevertheless, $2.851 billion—21.3% of RMI—was Level 3 at June 30. Bunge said the unobservable inputs primarily involved freight and location adjustments in interior Brazil and limited market corroboration in Canada. The company does not expect those inputs alone to have a material financial-statement effect because the positions generally do not extend beyond one crop cycle, but the classification refutes any implication that all RMI is exchange-priced cash. [S1]

Bunge priced $600 million of 5.000% senior unsecured notes due 2031 in August. The announced use was general corporate purposes, which could include refinancing short-term debt, working capital, capex, repurchases or investments; the release did not commit the proceeds exclusively to refinancing. The issue extends funding options but also illustrates the enlarged company’s continuing capital-market needs. [S14]

Cash flow and capital intensity

The contrast explains why a merchant requires two cash lenses. GAAP operating cash flow captures actual funding needs but swings violently with commodity prices and inventory. Management’s adjusted funds from operations and discretionary cash flow attempt to remove working-capital timing and identify capital available for growth and shareholders. The management measure is useful for cycle comparison but should not obscure debt and liquidity required to bridge the actual cash deficit. [S5][S18]

Net income frequently diverges from cash from operations because commodity prices and seasonal positioning move inventory, receivables, payables, margin deposits and hedge settlements; first-half 2026 inventory absorbed $2.24 billion and drove operating cash flow to negative $1.13 billion despite positive earnings.

There is a counterpoint omitted from the draft: H1 operating cash flow improved from negative $1.36 billion in H1 2025 to negative $1.13 billion in H1 2026. The deficit therefore should not be characterized as a unique deterioration. It still required funding. H1 capex was $779 million, acquisitions used $105 million, dividends used $275 million and repurchases used $249 million. Management’s adjusted framework reported $1.3 billion of adjusted funds from operations, $238 million of sustaining capex and $1.1 billion of discretionary cash flow. [S1][S3]

The business is highly working-capital-intensive and moderately fixed-capital-intensive: plants and logistics require continuing investment, while inventory, receivables, margin deposits and liquidity facilities make total economic capital substantially larger than reported capex alone.

Management guides to $1.5–$1.7 billion of 2026 total capex. The gap between sustaining capex and total spending reflects growth, productivity and project investment. Those dollars should remain in invested capital until projects prove commercial returns.

Off-balance-sheet and contingent obligations

Material economic obligations beyond funded debt include $1.65 billion of derecognized securitized receivables, $1.60 billion of operating-lease liabilities, guarantees, residual-value commitments, derivatives, purchase and transportation commitments, indemnities and legal or tax contingencies.

The receivables program was increased to $2 billion in March. At June 30, $1.650 billion of receivables had been sold and derecognized, with another $299 million pledged. The legal program terminates in 2031, but individual purchaser commitments were scheduled to expire December 16, 2026 subject to requested 364-day extensions. That structure adds flexibility and transfers significant receivable exposure, but it is still an economically important source of recurring funding. [S1]

Lease liabilities were $502 million current and $1.096 billion noncurrent. Bunge disclosed $524 million of maximum guarantee exposure, while the amount based on drawn affiliate facilities was $180 million and the recorded guarantee liability was $15 million. Indemnification obligations recorded at $125 million carried stated maximum potential payments of $1.6 billion. Brazilian authorities asserted approximately $163 million of ICMS claims and $598 million of PIS/COFINS claims; asserted amounts are not adjudicated or probable liabilities. [S1]

Lease treatment must be consistent in return analysis. Adding lease liabilities to invested capital while leaving all lease expense in operating profit biases returns down; ignoring both can impair comparisons to asset-owning peers. Public segment data do not support a fully matched bespoke lease-adjusted ROIC, so both obligations and management’s reported return measures are shown without false precision.

Accounting changes and controls

No material recognition-policy change was disclosed in Q2. The meaningful comparability changes are Viterra consolidation, final purchase-price allocation, segment renaming and future expense-disaggregation disclosure. A forthcoming FASB standard expands expense disclosure for fiscal years beginning after December 15, 2026 but is not expected to change recognized amounts. [S1]

Verdict: Financial quality is mixed. Filing-adjusted reconciliation, large liquidity and historically strong peak cash generation support the franchise. Against that, current conventional returns are modest, working capital requires substantial financing, one-fifth of RMI uses Level 3 inputs, merger adjustments remain heavy and acquisition-era per-share data are easy to misstate. The balance sheet is financeable, not capital-light.

Capital Allocation

Management’s framework prioritizes investment-grade ratings and an adjusted-leverage range of 2.0–2.5 times, then sustaining investment, risk-adjusted growth and shareholder returns. It intends to return at least 50% of discretionary cash flow across the cycle. Current 1.9-times adjusted leverage appears below the range, but standard debt, working-capital seasonality and ratings constraints explain management’s caution on the new authorization. [S3][S5]

Management defines distributable capacity through discretionary cash flow rather than GAAP free cash flow and intends to return at least 50% across the cycle, while currently prioritizing working-capital normalization, credit quality and completion of existing projects.

The framework is sensible if discretionary cash flow fully recognizes sustaining investment, integration costs, joint-venture funding and normalized working capital. It becomes aggressive if RMI credit substitutes for permanent debt reduction or if repurchases absorb cash before project and acquisition returns are demonstrated.

Viterra acquisition

Viterra is the defining allocation decision. Sellers received 65.6 million Bunge shares valued at $5.340 billion and $1.880 billion of cash. Bunge repaid $3.554 billion of specified Viterra debt and recorded a negative $157 million settlement of pre-existing relationships, producing $10.617 billion of accounting purchase consideration. Sellers initially owned approximately 33% of Bunge. [S1]

Viterra is strategically coherent and early operating evidence is improving, but its acquisition return remains unproven because only four full reported quarters of combined operations exist, the cycle is supportive, and accounting consideration was $10.62 billion before integration costs.

Strategic logic is not the same as financial success. The proper numerator is incremental after-tax cash earnings net of integration and sustaining costs. The denominator includes share consideration at acquisition-date value, cash, repaid debt, assumed obligations and incremental capital. EPS accretion can be created by financing or repurchases even when acquisition returns are weak.

Final purchase accounting added $2.880 billion of Viterra goodwill, including a $574 million measurement-period increase. No Viterra goodwill is expected to be tax deductible. The adjustment does not itself prove overpayment, but it raises the portion of the purchase price dependent on future cash flows and synergies. [S1]

Governance also changed. Glencore and CPP Investments each received the right to nominate two directors while maintaining at least 10% ownership, giving major sellers ongoing board representation. This can provide industry knowledge and alignment, but it also means strategic governance reflects concentrated legacy owners as well as dispersed shareholders. [S7]

Reinvestment and smaller transactions

The project portfolio carries an approximately 1.7-times-WACC stated hurdle. Investors should score Avondale, Morristown, Destrehan and Westzaan on actual commercial utilization, after-tax cash contribution and incremental invested capital. A management EPS bridge is not a substitute for individual project returns. [S3][S5]

The $105 million IFF transaction is small relative to Viterra and has a relatively tangible preliminary asset allocation. Its return is not yet measurable because qualification and production ramp continue. The European spreads sale and Brazilian sugar-mill divestiture simplify the portfolio; only the former has disclosed approximate consideration, and neither has a completed post-tax return reconciliation. [S1][S15]

Repurchases, issuance and dilution

The completed $2.7 billion program retired 28.38 million shares at an estimated $95.13 average, but Q2’s 1.97 million shares cost $126.85 each and period-end shares declined only 1.30 million from year-end because issuance partly offset repurchases.

The cumulative average was favorable relative to $124.59. The final tranche was above the current price and therefore has not created mark-to-market value. The Q2 release describes completion of the $2 billion Viterra-related commitment, while the filing shows that the legal authorization under which purchases occurred totaled $2.7 billion. Both statements are correct but refer to different denominators. [S1][S2]

A new $3 billion authorization approved in March remained unused at June 30 and has no fixed expiration. Authorization is optionality, not a forecast. Repurchases create value when shares trade below conservative intrinsic value and the balance sheet can absorb a downturn. They destroy flexibility when funded procyclically against transient earnings or when awards and issuance offset much of the retirement.

The large recent issuance was acquisition consideration, not insider compensation. H1 share-based compensation expense was $53 million. The latest inspected Form 4 reported 253 shares for COO Julio Garros under a restricted-unit dividend feature at $119.25; transaction code A and the explanatory footnote establish that it was an award-related addition, not an open-market purchase. [S1][S17]

There is no verified evidence of material discretionary stock issuance to insiders; recent insider additions were restricted-unit awards or dividend equivalents rather than open-market conviction purchases.

That conclusion is deliberately narrower than saying no insider ever purchased or sold shares. Awards, vesting, tax withholding, options, sales and genuine code-P purchases must be separated transaction by transaction.

Dividend

The annual dividend is $2.88 per share, paid as four $0.72 installments, and equals approximately 30% of the 2026 guidance midpoint; earnings coverage is comfortable, but durable coverage should be measured against cycle-adjusted discretionary cash flow.

The annual rate increased by $0.08. At $124.59, the indicated yield is approximately 2.3%. Under Swiss law, distribution remains subject to the relevant board and shareholder approvals. [S1][S20]

Compensation and management motivation

Executive compensation uses adjusted profit before tax, three-year cumulative EPS, three-year average adjusted ROIC and relative TSR, aligning pay with earnings and returns while retaining adjustment and acquisition-scale risk.

For 2025, long-term awards were 60% performance-based restricted units and 40% time-based units. Performance awards weight cumulative EPS and average adjusted ROIC equally, with a relative-TSR modifier of up to plus or minus 25%. Annual incentives use adjusted profit before tax plus a scorecard. The trading executive’s separate risk-adjusted-profit metric deducts working- and risk-capital charges, although targets are not disclosed. [S7]

The 2023–25 performance award illustrates both discipline and discretion. It paid at 59% of target after 90% EPS achievement, 78% adjusted-ROIC achievement and a negative relative-TSR adjustment. The committee adjusted targets for Viterra-related dilution and methodology changes. Such discretion can preserve an award’s original economics, but it also makes acquisition-period pay harder to audit.

The separate integration award grants performance units tied to cumulative run-rate cost synergies from 2026–28. This directly aligns executives with integration speed. Its weakness is that run-rate gross cost savings are not the same as net cash value. The ideal counterweight is public disclosure of costs, inflation, stranded expense and segment contribution. [S8]

Management’s incentives and behavior imply a preference for scale, portfolio simplification, investment-grade funding and explicit shareholder returns, but the special synergy award and above-current-price final buyback tranche make transparent net-return measurement essential.

Verdict: Allocation has been strategically coherent and often disciplined, but the largest decision cannot yet be scored. The cumulative buyback average is favorable, the latest tranche is mixed, and the new authorization provides useful flexibility. Incentives include returns and relative performance, yet merger adjustments and a run-rate synergy award require careful scrutiny of net cash outcomes.

Changes and Headwinds — Last Two Years

The operating environment changed materially through the Viterra close, renewable-fuel rules, higher physical biofuel demand, expanded processing activity, volatile trade routes and a larger project portfolio.

Strategy, transactions and reporting perimeter

Viterra closed July 2, 2025 and transformed the company’s geographic mix, debt, share count and segment reporting. Comparative Q2 and H1 2025 statements exclude Viterra, so much of reported 2026 growth is acquisition consolidation. Bunge finalized Viterra purchase accounting in Q2 2026 and added $574 million to goodwill. [S1]

Bunge acquired the IFF soy-protein, lecithin and crush assets in March 2026. It continued the planned European margarine and spreads disposal and agreed in September to sell two inherited Brazilian sugarcane mills. These actions concentrate capital around origination, oilseeds, refining and selected specialty products, but disclosed proceeds and completed returns remain incomplete. [S1][S15]

Internal and external earnings drivers

Results reflect both internal and external forces, but synchronized Bunge and ADM guidance increases show that crush, energy and biofuel conditions set much of the profit level while Viterra synergies and asset utilization determine Bunge’s relative result.

Bunge’s 2026 adjusted guidance began at $7.50–$8.00, increased to $9.00–$9.50 after Q1 and rose again to $9.25–$9.75 after Q2. Cost savings, commercial coordination and project ramps are internal. Renewable obligations, energy prices, crop availability, farmer selling, freight, export taxes and geopolitical disruption are external. ADM’s parallel $1-per-share guidance increase is strong evidence against treating the whole change as Bunge-specific. [S2][S3][S13][S21]

Management raised its soybean outlook, slightly raised softseeds, left Tropical Oils and Specialty Ingredients unchanged and lowered Grain Merchandising and Milling. It said the environment remained complex, particularly in Q4. Brazil faced slower farmer selling and local biofuel timing; food customers were buying shorter; grain and freight conditions were mixed. These cautions contradict straight-line extrapolation from Q2’s GAAP segment EBIT. [S3]

Policy and trade

The March final RFS rule was supportive and actual soybean-oil use increased. The August exemption decisions reduced current obligations by more than previously projected, while EPA’s announced 100% incremental reallocation remained a future proposal. Final economics therefore depend on both legal implementation and how competing feedstocks respond. [S9][S10][S11]

Conflict affecting energy and freight can help and hurt the same company. Higher energy prices can improve biofuel economics; disrupted freight can widen merchandising opportunities; operational interruption, sanctions, counterparty exposure and bunker cost can destroy value. Bunge’s Q2 filing attributed some higher vegetable-oil prices and demand to conflict with Iran, while management still described regional complexity. [S1][S3]

Facilities and management

Important market, facility and management changes include Viterra network integration, Morristown customer qualification, Avondale and Destrehan commissioning, Westzaan construction, portfolio divestitures and an announced chief-accounting-officer succession.

Matt Simmons plans to retire as controller and chief accounting officer on March 31, 2027. Richard James, currently responsible for finance integration and transformation and formerly corporate controller, will succeed him April 1. The filing says the retirement did not result from a disagreement. The transition is orderly but occurs while systems integration, purchase accounting and project accounting remain demanding. [S16]

The September Barclays event occurred after Q2, but the investor page provided no new filed quantitative outlook. It should not be treated as a hidden guidance update. The latest verified quantitative company outlook remains the July release and call. [S3]

Accounting policies

No material recognition-policy change was reported; Viterra consolidation, final purchase accounting, the segment-name change and future expense-disaggregation disclosure are the principal comparability changes.

The absence of a recognition change does not make comparisons simple. The acquisition changed reporting scale, weighted shares, goodwill, debt, noncontrolling interest, corporate cost and segment composition. Pro-forma volumes, adjusted EBIT, conventional returns and cash returns should be compared together. [S1][S6]

Verdict: The last two years strengthened Bunge’s scale and opportunity set while adding integration, funding, policy and comparability dependencies. Internal execution is promising, but external conditions still dominate the earnings level. The most important new headwinds are visibility after Q3, capacity response, working-capital finance and the risk of rewarding gross synergies before net returns appear.

Risk Analysis

The most likely causes of a material stock decline are weaker crush spreads, adverse biofuel implementation, Viterra benefit slippage, persistent working-capital funding and multiple compression from an elevated five-year price position.

These risks are correlated. Weaker margins reduce cash generation; inventories may still require financing; ratings and repurchase capacity tighten; and investors may reduce the multiple assigned to normalized earnings. The same biofuel disappointment can lower oil demand, compress crush, delay projects and reduce confidence in the $13 bridge.

The balance-sheet risk is not simply gross debt. In an ordinary cycle, inventory can be sold and working-capital borrowing declines. In stress, falling or dislocated markets can create basis losses, margin calls, transport constraints and counterparty failures. Receivables securitization purchasers can also become more selective even when the legal program remains in place.

A catastrophic loss would most plausibly require simultaneous working-capital stress, hedge or counterparty failure, impaired RMI liquidity, operating disruption and loss of capital-market access; no single ordinary crush downturn appears sufficient.

A plausible pathway would involve a commodity or basis shock that requires cash collateral; counterparties fail; Level 3 location discounts widen; inventory cannot move; commercial-paper access contracts; ratings fall; and legal or sanctions exposure creates additional claims. Facilities, diversified assets and essential demand make this unlikely, not impossible. [S1][S3][S6]

Total loss is very unlikely because Bunge owns globally useful assets, maintains substantial liquidity and serves essential demand, but equity drawdowns of 40% or more remain plausible if normalized EPS and the multiple contract together.

The five-year record already contains an approximately 41% decline from around $115 to $67.40 without insolvency. A cyclical equity can suffer severe permanent loss for a purchaser even when the enterprise survives and later recovers. [S18]

Mitigants should not be overstated. Hedging reduces flat-price risk but creates basis and collateral exposure. Diversification creates route alternatives but adds jurisdictions and operational complexity. RMI is liquid relative to plants but is not cash. The dividend supports holding-period return but does not prevent a cyclical reset.

Verdict: Permanent impairment is low probability, while severe cyclical drawdown is a realistic investment risk. The primary hazard is paying a higher multiple for earnings that blend policy support, spot spreads and unfinished merger benefits. A normal downturn is unlikely to threaten the enterprise; a correlated funding and operational shock is the tail scenario that matters.

Valuation Discussion

At $124.59 and approximately 192.1 million shares, equity value is about $23.9 billion. Adding June funded debt of $15.21 billion and $1.39 billion of noncontrolling interests, then deducting cash and near-cash items, produces a conventional enterprise value near $39.7–$39.9 billion. Treating $1.65 billion of derecognized receivables as additional economic funding raises the broader figure toward $41.4 billion. [S1][S18]

Management’s inventory-adjusted view produces a materially lower enterprise-capital measure. Using approximately $6.7 billion of adjusted net debt including its RMI credit and securitization treatment, plus noncontrolling interests, produces an adjusted enterprise figure near $32 billion. With trailing adjusted EBITDA around $3.6 billion, the conventional approach implies approximately 11.0–11.5 times EBITDA, while the management-style inventory-adjusted view is near 8.9 times. Neither is uniquely correct: conventional EV can overstate permanent capital by treating saleable crops like fixed assets; the adjusted view can understate stress risk by crediting inventory before cash realization. [S1][S3]

At the 2026 adjusted guidance midpoint of $9.50, the equity trades at 13.1 times earnings. It trades at 10.8 times the independent $11.50 normalized estimate and 9.6 times management’s approximately $13 bridge. The indicated dividend yield is about 2.3%. Book value is approximately $83.04 per June share and tangible book approximately $64.08, implying 1.50 times book and 1.94 times tangible book.

Book is a cross-check, not liquidation value. Inventory can realize near market but carries location and basis risk. Specialized plants may be worth more than depreciated book when permits and routes are scarce or less when capacity is redundant. Goodwill has no independent liquidation value.

Deconstructing the $13 bridge

The bridge is useful because it identifies management’s value-creation claims. It is dangerous if treated as a reported run rate. The current guidance midpoint is $1.75 above the bridge’s starting point, but much of that increase may overlap the $2.10 margin-normalization step. Adding $1.75 to $13 would double-count the same favorable environment. Similarly, the raised synergy objective does not automatically increase the bridge until management discloses timing, costs and overlap. [S3][S5]

A reasonable independent normalization process gives full credit to the enlarged network’s existence, partial credit to cost savings and projects, limited credit to opaque commercial benefits, and no automatic premium for repurchases. It also recognizes that 2019–25 adjusted EPS ranged from $4.76 to $13.91, with a median near $9.19 and average around $10.6 before a full-year Viterra contribution. Approximately $11.50 is therefore plausible but not precise.

Peer and historical context

ADM’s $86.91 price equals about 16.2 times its $5.375 guidance midpoint. Bunge’s lower forward P/E may compensate for greater merger and balance-sheet complexity, or it may represent relative value if Viterra raises resilience. Because both guides are supported by the same policy and crush conditions, ADM cannot serve as an independent cycle-normalized anchor. [S13][S18]

Historical P/E percentiles based on trough GAAP EPS are unreliable. Bunge’s share count, debt, asset mix and earnings base changed materially with Viterra. Price-to-sales is also weak because commodity prices dominate revenue. The more useful historical comparison is normalized EPS, conventional and adjusted enterprise value, tangible book, and returns achieved at the assumed earnings level.

Scenario analysis

The revenue ranges are deliberately secondary. A lower commodity-price environment can reduce revenue and working capital while improving or preserving spreads. The bear case assumes new capacity and weaker policy compress margins, projects deliver only partial returns, debt constrains repurchases and the market applies a cyclical multiple. The base case grants most cost savings, partial network and project benefits, ordinary financing and modest net share retirement. The bull case assumes the management bridge is largely delivered, projects meet hurdles and repurchases occur without weakening credit.

Weights of 25% bear, 50% base and 25% bull yield approximately $127 before dividends. The distribution is wide: a seemingly modest change in normalized EPS dominates nominal revenue assumptions. The downside also arrives through both earnings and multiple, while upside requires execution and durable margins simultaneously.

What the market embeds

The present quotation discounts more than the 2026 guide and less than full $13 delivery. It can be justified by approximately $10.5–$11.5 of normalized EPS at an 11–12-times multiple, or by $13 at a sub-10-times multiple. The market correctly recognizes that FY2025 GAAP EPS was burdened by timing and merger costs and that Viterra increases potential earnings. It may be underpricing overlap between the guidance uplift and management’s normalization bridge.

The fragile bull assumptions are the $1.30 project contribution, observable realization of the $90 million commercial target, supportive policy and disciplined repurchases. The fragile bear assumption is that approximately $8 remains the best post-merger normal despite a larger network, higher cost-saving target and observable biofuel volume.

Verdict: Valuation is defensible only if post-Viterra normalized earnings exceed the old standalone-style base. The quotation does not require all of management’s $13 bridge, but it offers limited protection if earnings return to $8. The most useful valuation discipline is to separate demonstrated earnings, cycle normalization, operating execution and capital actions instead of capitalizing one blended management label.

Variant Perception

The constructive market view is that Viterra created a leading origin-to-destination platform as renewable-fuel demand structurally tightened vegetable-oil balances. Under that view, 2026 guidance is transitional, approximately $13 is the proper baseline, $15-plus is achievable by 2030 and diversification merits a higher multiple.

The skeptical view is that Bunge combined two capital-intensive spread businesses during a policy-supported cycle. Cost savings will be competed away, capacity will catch demand, projects will consume capital and management’s prospective bridge will be mistaken for current earnings. Under that view, normalized EPS can still return toward $8.

The evidence supports a middle variant: $8 is too narrow as the sole base case, while $13 remains unearned. The combined company is more valuable than standalone Bunge under reasonable assumptions, but it is not yet a stable compounder. Investors have already recognized much of that middle ground.

The highest-value investor questions are how much of the $350 million cost-synergy target is already in reported profit, how much of 2026 guidance depends on spot margins, what is booked for fourth quarter and 2027, and when projects convert from commissioning claims into cash ROIC.

Other critical questions are why adjusted leverage rose while remaining below management’s target range, what standard-debt threshold governs the new authorization, how commercial synergies will be separated from industry spreads, and whether executive synergy awards measure gross actions or net cash value. These questions emerge directly from the Q2 analyst exchange, the Investor Day bridge and the incentive filing. [S3][S5][S8]

Strongest bull case

Physical and operating evidence is improving. US soybean-oil biofuel use is much higher, final renewable obligations are supportive, both listed processors raised guidance, Bunge raised its cost-synergy objective, and funded projects are commissioning. A broader network can source around regional crop problems and direct product toward the best destination. If conventional ROIC rises alongside adjusted ROIC and cash conversion improves through a weaker spread period, Viterra would be an economic transformation rather than only a scale transaction. [S3][S9][S11][S13]

Strongest bear case

The favorable evidence may simply describe a synchronized industry cycle. ADM’s result shows that policy, energy and crush explain much of the uplift. First-half cash flow remained negative, debt increased on a filing-comparable basis, Q4 visibility was limited and a material part of RMI used Level 3 inputs. The $13 bridge includes projects, capital allocation and policy assumptions. A larger asset base can amplify fixed-cost pressure when capacity catches demand. [S1][S3][S5]

Load-bearing assumptions

1. Normalized margins. The base case assumes margins above the 2024–25 trough and below 2023. It fails if normal-crop adjusted EPS falls below $8.50 without a broad recession.
2. Net synergy realization. Most of the $350 million cost objective and $90 million commercial target must become incremental cash profit. It fails if run-rate savings rise while segment contribution, cash flow and ROIC stagnate.
3. Policy-supported physical demand. Renewable rules must continue driving feedstock use. It fails if final exemptions, tax treatment or competing feedstocks materially reduce soybean-oil consumption.
4. Project returns. The $1.30 pipeline must produce acceptable after-tax returns. It fails if qualification slips, capex rises or contribution remains below the stated hurdle.
5. Capital discipline. Debt and working capital must normalize before large new repurchases. It fails if the authorization is used aggressively while standard debt and securitization remain elevated.

Factor and positioning context

The September 9 factor model reports positive statistical exposures to NewDividend (0.445), Energy-sector returns (0.441), OilPrice (0.420), Market (0.324), Materials-sector returns (0.254) and CreditRisk (0.243), with negative Growth (−0.169) and BetaFactor (−0.164) exposures. Explanatory power is low: R-squared is 0.237 and adjusted R-squared is 0.221. Residual momentum is 0.019, residual Sharpe 0.458 and residual volatility 0.250. [S19]

These are internal statistical diagnostics, not legal classifications or causal fundamentals. Energy exposure does not make Bunge an energy company; it can reflect biofuel, freight and commodity co-movement. The previous Value exposure is absent and should not be repeated. Low explanatory power means crop, policy, integration and company-specific evidence dominate the investment judgment.

Verdict: The differentiated view is decomposition, not a slogan. The business probably earns more than the prior standalone-style base, but the full management bridge requires several unfinished events. The edge lies in distinguishing shared industry uplift from net company execution and in demanding cash-return proof.

Fact vs. Interpretation

The central errors to avoid are treating a management bridge as current fact, using year-end shares for transaction-year EPS, accepting adjusted leverage without its inventory and securitization assumptions, and attributing peer-wide margin improvement entirely to company execution.

Open Questions

The following uncertainties should change estimates only when answers reconcile to cash flow, capital employed and per-share outcomes. They arise from unresolved disclosure in the filing, Investor Day bridge and Q2 call. [S1][S3][S5]

1. How much of the $350 million cost objective is already in 2026 guidance and reported adjusted EBIT?
2. What cash integration cost remains, and how much of gross savings is offset by inflation, retention or dis-synergies?
3. What precise definitions and thresholds govern the executive integration award?
4. How much of the current guide comes from spot US crush, renewable-fuel rules, energy and Viterra execution?
5. What Q4 and early-2027 volumes and spreads are already booked?
6. Does the approximately $13 bridge use current diluted shares or assumed future repurchases, and at what price?
7. What after-tax contribution and invested capital correspond to each project in the $1.30 pipeline?
8. When will Avondale, Morristown, Destrehan and Westzaan reach customer-qualified commercial utilization?
9. How much of the Q1-to-Q2 increase in net debt versus RMI is seasonal, and when should it reverse?
10. What standard-net-debt and liquidity thresholds govern use of the new $3 billion authorization?
11. How will management distinguish $90 million of network benefits from favorable industry spreads?
12. Can adjusted ROIC remain above 10%, with conventional ROIC improving, through a weaker US crush year?
13. What are the post-tax proceeds and accounting gains or losses on the European spreads and Brazilian mill sales?
14. How sensitive is 2027 EPS to final SRE reallocation, clean-fuel tax economics and Brazilian blending schedules?
15. Will the receivables purchasers extend their December 2026 commitments, and on what terms?
16. Why did Level 3 RMI rise from $1.407 billion at year-end to $2.851 billion, and what portion reflects Viterra geography rather than prices?
17. Will any material open-market insider purchase provide valuation confirmation after separating awards and dividend equivalents?

What Must Be True

Bull case tests

• The earnings base must be structurally higher. Adjusted EPS should remain at least $10 through 2027 under normal crop conditions without another discrete policy windfall. Monitoring signals are quarterly guidance, booked margins, peer crush results and physical feedstock use. The test fails if guidance falls below $8.50 or adjusted segment EBIT declines more than 25% during ordinary capacity normalization. [S2][S3][S11][S13]

• Synergies must be incremental, not merely reported. Bunge should deliver most of the $350 million cost objective and $90 million commercial target while integration costs decline and segment cash contribution rises. Monitoring requires the disclosed run rate, cash charges, EBIT per ton, utilization and ROIC. The case fails if certified savings increase while normalized segment profit and cash returns stagnate. [S3][S5][S8]

• Projects must earn their hurdle. Avondale, Morristown, Destrehan and Westzaan should progress from construction or commissioning to qualified utilization and contribute toward the $1.30 EPS bridge. Monitor startup dates, customer qualification, capex and incremental cash profit. Repeated delays, additional capital or returns below the stated approximately 1.7-times-WACC hurdle falsify the premise. [S3][S5]

• Viterra must improve downside resilience. Geographic and product diversity should offset regional weakness without merely adding fixed cost. Monitor combined-company EBIT and ROIC in a weak crop or crush year relative to ADM. The premise fails if Bunge declines as much as or more than less diversified peers after normalizing timing items. [S1][S5][S13]

• The funding model must normalize safely. Standard debt, Level 3 RMI and securitization dependence should decline or remain demonstrably liquid as seasonal inventories unwind. Monitor debt, RMI levels, Level 3 share, margin deposits, purchaser commitments and unused facilities. Persistent debt growth despite positive adjusted funds from operations would weaken the case. [S1][S3]

• Capital allocation must compound per-share value. Material use of the new authorization should follow working-capital normalization, and net shares should decline at prices below conservatively estimated value. Debt-funded repurchases during strong spreads or dilution that offsets most retirement would falsify the premise. [S1][S5]

Bear case tests

• The current uplift must prove predominantly cyclical. New processing supply must compress margins even as biofuel volume grows. Monitor regional crush spreads, utilization, ADM results and Bunge segment profit. Sustained $10-plus EPS and double-digit adjusted ROIC through weaker spot spreads would falsify this bear premise. [S3][S12][S13]

• Policy support must disappoint or be competed away. Final reallocation, tax-credit economics or foreign mandates must produce less feedstock tightness than expected. Monitor EPA implementation, RIN markets and monthly EIA consumption. Continued physical use materially above 2025 with no erosion in processor economics would weaken the bear case. [S9][S10][S11]

• The $13 bridge must be materially overstated. Projects, synergies, financing or repurchases must fail to arrive or overlap with already-improved guidance. An explicit reconciliation showing approximately $13 with declining integration costs, lower debt and no above-normal margins would falsify this premise. [S3][S5]

• The network must fail to improve returns. Combined-company conventional and adjusted ROIC must remain near capital cost despite claimed commercial benefits. Durable adjusted ROIC above 10%, improving conventional ROIC and better cash conversion during a normal cycle would disprove the claim that Viterra merely created a larger low-return merchant. [S1][S3][S5]

• The multiple must contract with earnings. A cyclical reset must reduce both EPS and investor willingness to capitalize it. Stable valuation through a full margin down-leg, supported by visibly lower earnings volatility, would falsify this element of the bear case. [S18][S19]

The practical thesis boundary is measurable. Normal-year adjusted EPS above $10, adjusted ROIC above 10%, improving conventional returns, declining integration expense, lower standard debt and transparent net synergy conversion would validate a stronger franchise. EPS below $8.50, unobservable network benefits, persistent funding dependence or policy-driven margin compression would show that investors capitalized a temporary cycle.

Core documents linked for reader verification: June 2026 Form 10-Q, Q2 earnings release, 2026 Investor Day, EPA final RFS rule, EIA biofuel inputs, and USDA soybean outlook.

Public source appendix

• S1: Bunge Global SA Form 10-Q for the quarter ended June 30, 2026 — SEC filing; published 2026-07-29; Condensed statements; Notes 2, 4, 5, 11, 13, 15–17; segment MD&A; liquidity, cash-flow and repurchase tables
• S2: Bunge reports second-quarter 2026 results — Company earnings release; published 2026-07-29; Q2 and H1 results, adjusted-EPS reconciliation, segment results and 2026 outlook
• S3: Bunge second-quarter 2026 earnings conference-call transcript — Company transcript; published 2026-07-29; Prepared remarks and Q&A on guidance, Q4 visibility, synergies, projects, RMI, leverage, liquidity and allocation
• S4: Bunge outlines long-term financial outlook and capital-allocation framework — Company investor-day release; published 2026-03-10; Approximately $13 run-rate baseline, $15-plus 2030 ambition, cash-return framework and authorization
• S5: Bunge 2026 Investor Day presentation — Company presentation; published 2026-03-10; Pages 29–41, 73–90 and 100–108: scale, projects, synergy run rate, EPS bridge, policy assumptions, ROIC, cash flow and leverage
• S6: Bunge Global SA 2025 Form 10-K — SEC filing; published 2026-02-19; Items 1, 7 and 8; audited statements; segment, Viterra, debt, cash-flow and share-count disclosures
• S7: Bunge Global SA 2026 proxy statement — SEC proxy filing; published 2026-04-10; Pages 18, 40–66 and 84–87: seller nomination rights, director awards, annual/LTI metrics, target adjustments and ownership
• S8: Bunge Form 8-K establishing the Executive Integration Incentive Program — SEC filing; published 2026-04-01; Item 5.02: one-time PBRSUs based on cumulative run-rate cost-synergy targets for 2026–28
• S9: EPA final renewable-fuel standards for 2026 and 2027 — Government regulation; published 2026-03-27; Rule summary and table of 2026–27 volume requirements, SRE reallocation and applicable volumes
• S10: EPA action on 2025 small-refinery exemptions and related actions — Government announcement; published 2026-08-31; Petition decisions, 1.76 billion exempted RINs and announced plan to propose incremental reallocation
• S11: US soybean-oil inputs to biofuel production — Government statistical series; published 2026-08-31; Monthly million-pound series through June 2026; release date August 31, 2026
• S12: USDA soybeans and oil-crops market outlook — Government market outlook; published 2026-08-14; August 2026 US production, crush, stocks and global soybean meal/oil outlook
• S13: ADM reports second-quarter 2026 results — Peer company earnings release; published 2026-08-04; Raised adjusted-EPS guidance, Ag Services & Oilseeds results, crush, RVO, energy and timing commentary
• S14: Bunge prices $600 million of 5.000% senior notes due 2031 — Company financing release; published 2026-08-17; Principal amount, coupon, maturity, expected closing and permitted general-corporate uses
• S15: Bunge agrees to sell two Brazilian sugarcane mills to COFCO International — Company transaction release; published 2026-09-01; Assets, buyer and closing conditions; consideration not disclosed
• S16: Bunge Form 8-K announcing controller and chief accounting officer succession — SEC filing; published 2026-09-03; Item 5.02: Matt Simmons retirement, absence of disagreement and Richard James appointment
• S17: Bunge Form 4 for Julio Garros — SEC insider filing; published 2026-09-02; Transaction code A and footnote identifying 253 shares as restricted units acquired under a dividend feature
• S18: Company Financials — NYSE:BG and NYSE:ADM profile, financial and market series — Company Financials dataset; published 2026-09-10; NYSE:BG resolved as primary symbol; annual statements and ratios, Q1/Q2 transcripts and split-adjusted prices through September 10, 2026; filing values govern conflicts
• S19: Factor model snapshot dated September 9, 2026 — Internal quantitative diagnostic; published 2026-09-09; Statistical factor exposures, residual diagnostics, R-squared and adjusted R-squared
• S20: Bunge 2026 dividend approval and payment schedule — Company dividend release; published 2026-05-20; Annual $2.88 distribution in four $0.72 installments
• S21: Bunge Global SA Form 10-Q for the quarter ended March 31, 2026 — SEC filing; published 2026-04-29; Q1 financial statements, mark-to-market context, debt, RMI, liquidity and MD&A
• S22: Bunge Global SA 2024 Form 10-K — SEC filing; published 2025-02-20; 2022–24 audited statements, segment results, risks, cash flow and pre-Viterra balance sheet
• S23: Bunge Global SA 2023 Form 10-K — SEC filing; published 2024-02-22; 2021–23 audited statements, segment cycle context and cash-flow disclosures